Cellosaurus cell line CDina26 (CVCL

Cellosaurus CDina26 (CVCL_A0IM)

Cross-references
Cell line name	CDina26
Synonyms	BT 5/9; BT5/9; 5/9
Accession	CVCL_A0IM
Resource Identification Initiative	To cite this cell line use: CDina26 (RRID:CVCL_A0IM)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 12002. Biotechnology: Was used to produce the monoclonal antibody begelomab (Begedina) which was evaluated as a therapeutic agent against steroid-resistant acute graft-versus-host disease. Monoclonal antibody isotype: IgG2b. Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_3412 (P3X63Ag8U.1)
Category	Hybridoma
Publications	PubMed=6459366; DOI=10.4049/jimmunol.128.1.16 Corte G., Mingari M.C., Moretta A., Damiani G., Moretta L., Bargellesi A. Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation. J. Immunol. 128:16-19(1982) Patent=US9376498 Di Naro A.F. Anti-CD26 antibodies and uses thereof. Patent number US9376498, 28-Jun-2016 Patent=US10208126 Di Naro A.F. Methods of treating aplastic anemia by administering anti-CD26 antibodies. Patent number US10208126, 19-Feb-2019
Biological sample resources	ABCD; ABCD_AA723
Encyclopedic resources	Wikidata; Q108820000
Entry history
Entry creation	23-Sep-2021
Last entry update	21-Mar-2023
Version number	3